139 related articles for article (PubMed ID: 25398597)
1. Differential modulation of S1PR(1-5) and specific activities of SphK and nSMase in pulmonary and cerebral tissues of rats exposed to hypobaric hypoxia.
Chawla S; Saxena S
Lipids; 2015 Jan; 50(1):39-48. PubMed ID: 25398597
[TBL] [Abstract][Full Text] [Related]
2. Acute Hypobaric Hypoxia-Mediated Biochemical/Metabolic Shuffling and Differential Modulation of S1PR-SphK in Cardiac and Skeletal Muscles.
Rahar B; Chawla S; Tulswani R; Saxena S
High Alt Med Biol; 2019 Mar; 20(1):78-88. PubMed ID: 30892968
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis.
Yang L; Yue S; Yang L; Liu X; Han Z; Zhang Y; Li L
J Hepatol; 2013 Jul; 59(1):114-23. PubMed ID: 23466305
[TBL] [Abstract][Full Text] [Related]
4. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.
Tabeling C; Yu H; Wang L; Ranke H; Goldenberg NM; Zabini D; Noe E; Krauszman A; Gutbier B; Yin J; Schaefer M; Arenz C; Hocke AC; Suttorp N; Proia RL; Witzenrath M; Kuebler WM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1614-23. PubMed ID: 25829545
[TBL] [Abstract][Full Text] [Related]
5. Preventive preclinical efficacy of intravenously administered sphingosine-1-phosphate (S1P) in strengthening hypoxia adaptive responses to acute and sub-chronic hypobaric hypoxia.
Chawla S; Rahar B; Tulswani R; Saxena S
Eur J Pharmacol; 2020 Mar; 870():172877. PubMed ID: 31866409
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
[TBL] [Abstract][Full Text] [Related]
7. Exogenous sphingosine-1-phosphate boosts acclimatization in rats exposed to acute hypobaric hypoxia: assessment of haematological and metabolic effects.
Chawla S; Rahar B; Singh M; Bansal A; Saraswat D; Saxena S
PLoS One; 2014; 9(6):e98025. PubMed ID: 24887065
[TBL] [Abstract][Full Text] [Related]
8. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
[TBL] [Abstract][Full Text] [Related]
9. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease.
Pyne S; Lee SC; Long J; Pyne NJ
Cell Signal; 2009 Jan; 21(1):14-21. PubMed ID: 18768158
[TBL] [Abstract][Full Text] [Related]
10. The effect of hypoxia on lipid phosphate receptor and sphingosine kinase expression and mitogen-activated protein kinase signaling in human pulmonary smooth muscle cells.
Ahmad M; Long JS; Pyne NJ; Pyne S
Prostaglandins Other Lipid Mediat; 2006 May; 79(3-4):278-86. PubMed ID: 16647641
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
Schnitzer SE; Weigert A; Zhou J; Brüne B
Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase and sphingosine 1-phosphate in asthma.
Lai WQ; Wong WS; Leung BP
Biosci Rep; 2011 Apr; 31(2):145-50. PubMed ID: 21091442
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.
Yang Y; Torta F; Arai K; Wenk MR; Herr DR; Wong PT; Lai MK
Neurochem Int; 2016 Mar; 94():90-7. PubMed ID: 26921668
[TBL] [Abstract][Full Text] [Related]
14. The role of sphingolipids in respiratory disease.
Yang Y; Uhlig S
Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
[TBL] [Abstract][Full Text] [Related]
15. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme.
Bien-Möller S; Lange S; Holm T; Böhm A; Paland H; Küpper J; Herzog S; Weitmann K; Havemann C; Vogelgesang S; Marx S; Hoffmann W; Schroeder HW; Rauch BH
Oncotarget; 2016 Mar; 7(11):13031-46. PubMed ID: 26887055
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.
Ito S; Iwaki S; Koike K; Yuda Y; Nagasaki A; Ohkawa R; Yatomi Y; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2013 Dec; 24(8):642-50. PubMed ID: 24212262
[TBL] [Abstract][Full Text] [Related]
17. S1P prophylaxis mitigates acute hypobaric hypoxia-induced molecular, biochemical, and metabolic disturbances: A preclinical report.
Chawla S; Rahar B; Saxena S
IUBMB Life; 2016 May; 68(5):365-75. PubMed ID: 26959531
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
[TBL] [Abstract][Full Text] [Related]
19. A polysaccharides MDG-1 augments survival in the ischemic heart by inducing S1P release and S1P1 expression.
Wang S; Lin X; Wang LY; Ruan KF; Feng Y; Li XY
Int J Biol Macromol; 2012 Apr; 50(3):734-40. PubMed ID: 22197795
[TBL] [Abstract][Full Text] [Related]
20. Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).
Barnawi J; Tran H; Jersmann H; Pitson S; Roscioli E; Hodge G; Meech R; Haberberger R; Hodge S
PLoS One; 2015; 10(10):e0122771. PubMed ID: 26485657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
